Curriculum
Course Description:
- A bridging justification is an approach for safety assessments in which toxicology data for one or more compounds are applied to a different compound.
- Important elements of a bridging justification include the similarity and difference between excipients, existing nonclinical and clinical data, data gaps and the proposed context of use.
- The U.S. Office of Generic Drugs reviews bridging justifications within ANDAs to ensure excipient safety. Each case is unique, but similar principles apply.
Featuring Robert Dorsam, Ph.D., U.S. FDAAccess Duration:Access to this course expires 60 days from the date of registration or until you mark the course ‘Complete’ – whichever occurs first.